Logo - springer
Slogan - springer

Biomedical Sciences - Cancer Research | Immunosurveillance, Immunodeficiencies and Lymphoproliferations - Lymphoproliferative Disorders

Immunosurveillance, Immunodeficiencies and Lymphoproliferations

Lymphoproliferative Disorders in Congenital and Acquired Immunodeficiencies

Oertel, S.H., Riess, H. (Eds.)

2002, X, 158 p.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$129.00

(net) price for USA

ISBN 978-3-642-56352-2

digitally watermarked, no DRM

Included Format: PDF

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$219.00

(net) price for USA

ISBN 978-3-540-42282-2

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$169.00

(net) price for USA

ISBN 978-3-642-62676-0

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

  • About this book

This book covers lymphoproliferative disorders in patients with congenital or acquired immunodeficiencies. Acquired immunodeficiencies are caused by infections with the human immunodeficiency virus or arise following immunosuppressive therapy administered after organ transplantation or to treat connective tissue diseases such as rheumatoid arthritis. It was recently discovered that various diseases or therapeutic modalities that induce a state of immunosuppression may cause virally driven lymphoproliferations. This book summarizes for the first time this group of immunodeficiency-associated lymphoproliferations.

Content Level » Research

Keywords » AIDS lymphoma - Epstein-Barr-Virus - infections - tissue - transplantation

Related subjects » Cancer Research - Internal Medicine - Oncology & Hematology

Table of contents 

Immunosurveillance, Immunodeficiency and Lymphoproliferations.- Clinicopathological Characteristics of Post-Transplant Lymphoproliferative Disorders.- Latrogenic Lymphoproliferative Disorders in Non-Transplantation Settings.- The Role of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8) in Lymphoproliferative Diseases.- Dendritic Cells for the Induction of EBV Immunity.- NF-?B Inhibition in EBV-Transformed Lymphoblastoid Cell Lines.- Epstein-Barr Viral Load as a Tool to Diagnose and Monitor Post-Transplant Lymphoproliferative Disease.- The Role of Immunosuppression in Lymphoma.- Indentification of Prognostic Factors in Post-Transplant Lymphoproliferative Disorders.- Methods and Objectives of a Large US Multicenter Case-Control Study of Post-Transplant Lymphoproliferative Disorder in Renal Transplant Patients.- Antiviral Treatment of Epstein-Barr Virus-Associated Lymphoproliferations.- Low-Dose Chemotherapy for Children with Post-Transplant Lymphoproliferative Disease.- Engineered Antibody for Treating Lymphoma.- Treatment of Post-Transplant Lymphomas with Anti-B-Cell Monoclonal Antibodies.- Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes for the Prevention and Treatment of EBV-Associated Post-Transplant Lymphomas.- Non-Myeloablative Stem Cell Transplantation for Congenital Immunodeficiencies.- Prognostic Factors in the Treatment of Human Immunodeficiency Virus-Associated Non-Hodgkin’s Lymphoma.- Infusional CDE with Rituximab for the Treatment of Human Immunodeficiency Virus-Associated Non-Hodgkin’s Lymphoma: Preliminary Results of a Phase I/II Study.

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Cancer Research.